Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Sophie Nahon"'
Autor:
Anne-Laure Couderc, Emilie Nouguerède, Karine Baumstarck, Sandrine Loubière, Hervé Le Caer, Olivier Guillem, Frédérique Rousseau, Laurent Greillier, Emmanuelle Norguet-Monnereau, Maud Cecile, Rabia Boulahssass, Françoise Le Caer, Sandrine Tournier, Chantal Butaud, Pierre Guillet, Sophie Nahon, Sylvie Kirscher, Nadine Diaz, Claire Morando, Patrick Villani, Pascal Auquier, Aurélie Daumas
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-4 (2019)
Abstract Background Social isolation potentiates the risk of death by cancer in the older cancer patient population. The PREDOMOS study investigates the impact of establishing a Program of Social intervention associated with techniques of Domotic and
Externí odkaz:
https://doaj.org/article/91b2236af04440dcabfea5cd04311774
Autor:
Elodie Crétel-Durand, Emilie Nouguerède, Hervé Le Caer, Frédérique Rousseau, Frédérique Retornaz, Olivier Guillem, Anne-Laure Couderc, Laurent Greillier, Emmanuelle Norguet, Maud Cécile, Rabia Boulahssass, Francoise Le Caer, Sandrine Tournier, Chantal Butaud, Pierre Guillet, Sophie Nahon, Laure Poudens, Sylvie Kirscher, Sandrine Loubière, Nadine Diaz, Jean Dhorne, Pascal Auquier, Karine Baumstarck
Publikováno v:
Trials, Vol 18, Iss 1, Pp 1-11 (2017)
Abstract Background Cancer incidence and social isolation increase along with advanced age, and social isolation potentiates the relative risk of death by cancer. Once spotted, social isolation can be averted with the intervention of a multidisciplin
Externí odkaz:
https://doaj.org/article/2fc94308d89b4256a2bdc0d73b278a48
Autor:
Sophie Nahon, Frédérique Rousseau, Rabia Boulahssass, Francois Morvan, Dany Gholam, Olivier Guillem, Frédérique Retornaz, Michel Grino, Yves Rinaldi, Chantal Castagna
Publikováno v:
Oncologist
Oncologist, AlphaMed Press, 2020, 25 (1), ⟨10.1634/theoncologist.2019-0241⟩
Oncologist, 2020, 25 (1), ⟨10.1634/theoncologist.2019-0241⟩
Oncologist, AlphaMed Press, 2020, 25 (1), ⟨10.1634/theoncologist.2019-0241⟩
Oncologist, 2020, 25 (1), ⟨10.1634/theoncologist.2019-0241⟩
Purpose Older patients with colon cancer (CC) are vulnerable to chemotherapy toxicity and death. Establishing simple scores specific for patients with CC to predict severe chemotoxicity or early death is needed to select the best treatment strategy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d97ca14c5c9249d552afc6aacce1aa49
https://hal.inrae.fr/hal-02627825
https://hal.inrae.fr/hal-02627825
Double neoplasia: squamous cell carcinoma of the esophagus and gastric lymphoma on myasthenia gravis
Autor:
Sylvie Cailleres, Alina Zamfir, Thierry Allegre, Roxane Mari, Crescent Cossou-Gbeto, Abdelaziz Chaib, Régis Costello, Sophie Nahon
Publikováno v:
Hématologie. 23:191-194
IntroductionLa relation entre la lymphogenese et l’auto-immunite est actuellement bien decrite dans la litterature, mais il existe tres peu de donnees associant la survenue d’un cancer solide sur un terrain auto-immun.
Autor:
L'Houcine Ouafik, Crescent C Gbeto, Catherine Roche, Bruno Lacarelle, Sylvie Quaranta, Thierry Allegre, Sophie Nahon, Roxane Mari, Raphaelle Fanciullino, Caroline Solas, Joseph Ciccolini
Publikováno v:
Pharmacogenomics
Pharmacogenomics, Future Medicine, 2019, 20 (13), pp.931-938. ⟨10.2217/pgs-2019-0028⟩
Pharmacogenomics, 2019, 20 (13), pp.931-938. ⟨10.2217/pgs-2019-0028⟩
Pharmacogenomics, Future Medicine, 2019, 20 (13), pp.931-938. ⟨10.2217/pgs-2019-0028⟩
Pharmacogenomics, 2019, 20 (13), pp.931-938. ⟨10.2217/pgs-2019-0028⟩
Dihydropryimidine dehydrogenase (DPD) deficiency is a pharmacogenetic syndrome associated with severe or lethal toxicities with oral capecitabine. Usually, patients with history of 5-FU-based therapy with no signs for life-threatening toxicities are
Autor:
Emmanuelle Salort-Campana, Sébastien Küry, Stéphane Bézieau, Sébastien Barbarot, Sandra Mercier, Sophie Nahon
Publikováno v:
Pancreas
Pancreas, Lippincott, Williams & Wilkins, 2019, 48 (5), pp.e41-e42. ⟨10.1097/MPA.0000000000001303⟩
Pancreas, Lippincott, Williams & Wilkins, 2019, 48 (5), pp.e41-e42. ⟨10.1097/MPA.0000000000001303⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dcb7f9490c68ae6f29f200b1e62468a
https://hal.inrae.fr/hal-02627713
https://hal.inrae.fr/hal-02627713
Autor:
Frédérique Retornaz, Karine Baumstarck, Laurent Greillier, Sylvie Kirscher, Sophie Nahon, Sandrine Loubière, Laure Poudens, Chantal Butaud, Emmanuelle Norguet, Rabia Boulahssass, Anne-Laure Couderc, Pascal Auquier, Emilie Nouguerède, Francoise Le Caer, Sandrine Tournier, Pierre Guillet, Hervé Le Caer, Frédérique Rousseau, Jean Dhorne, Maud Cécile, Nadine Diaz, Olivier Guillem, Elodie Crétel-Durand
Publikováno v:
Trials
Trials, Vol 18, Iss 1, Pp 1-11 (2017)
Trials, Vol 18, Iss 1, Pp 1-11 (2017)
Background Cancer incidence and social isolation increase along with advanced age, and social isolation potentiates the relative risk of death by cancer. Once spotted, social isolation can be averted with the intervention of a multidisciplinary team.
Autor:
Chantal Butaud, Olivier Guérin, Frédérique Retornaz, Frédérique Rousseau, Yves Rinaldi, Nicolas Barriere, Rabia Boulahssass, Sophie Nahon, Olivier Guillem, Michel Grino, Jean-François Codoul, Cécile Brativesic, Dany Gholam, Francois Morvan
Publikováno v:
Journal of Clinical Oncology. 36:10041-10041
10041Background: Older patients with colon cancer are more vulnerable to chemotherapy toxicity and early death. Establishing simple scores specific for colon cancer (cc) patients able to predict se...
Autor:
Pierre Nouyrigat, Louis-Marie Dourthe, Hélène Albrand, Frédéric Maloisel, Nadia Ali Amar, Jean-Luc Labourey, Nacera Sakek, Miguel Carreiro, Elisabeth Luporsi, Vincent Boulanger, Bérengère Narciso, Mauricette Michallet, Daniel Lepille, Jean-Loup Mouysset, Sophie Nahon, Pierre Soubeyran, Raouf Radji
Publikováno v:
BMC Cancer
Background The approval of epoetin biosimilars in the European Union requires extensive scientific evaluation and stringent regulatory procedures, including post-marketing studies. The ORHEO (place of biOsimilaRs in the therapeutic management of anae
Autor:
Jean Philippe Metges, Jean-Pierre Crumbach, Daniela Petran, Vincent Boulanger, Otilia Stamerra, Jérôme Desramé, Sophie Nahon, Camille Aubron-Olivier, Domitille Fernet, Gilles Boschetti
Publikováno v:
Journal of Clinical Oncology. 33:742-742
742 Background: OncoBOS is a prospective, non-interventional study describing Binocrit use in routine practice in France in patients receiving chemotherapy treatment (CT) for solid tumors, lymphoma, or myeloma. This interim sub-analysis focuses on pa